Regulatory watch: What drives differences in review times among CDER divisions?
Nat Rev Drug Discov
.
2015 Oct;14(10):670-1.
doi: 10.1038/nrd4724.
Epub 2015 Aug 21.
Authors
Andreas Schick
1
,
Kathleen L Miller
1
,
Michael Lanthier
1
,
Janet Woodcock
2
Affiliations
1
Office of the Commissioner, 10903 New Hampshire Avenue, Silver Spring, Maryland 20993, USA.
2
Center for Drug Evaluation and Research at the US Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, Maryland 20993, USA.
PMID:
26294264
DOI:
10.1038/nrd4724
No abstract available
Publication types
News
MeSH terms
Drug and Narcotic Control*
United States
United States Food and Drug Administration*